HTA Database - Search Results

Sort by Relevance

Search Results [239 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	HAYES, Inc.	Percutaneous vertebroplasty
2012	HAYES, Inc.	Vitamin D supplementation in patients with osteoporosis
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 report
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Low-intensity ultrasound for the treatment of fractures]
2012	HAYES, Inc.	Vitamin D supplementation and risk of fractures, falls, and bone loss
2012	Agency for Healthcare Research and Quality (AHRQ)	Menopausal hormone therapy for the primary prevention of chronic conditions: systematic review to update the 2002 and 2005 U.S. Preventive Services Task Force Recommendations.
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis: clinical effectiveness and harms
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	[Surgical stabilization of a flail chest wall]
2011	Adelaide Health Technology Assessment (AHTA)	Review of interim funded service: vertebroplasty and new review of kyphoplasty
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Percutaneous acrylic vertebroplasty for the treatment of vertebral fractures]
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	[Surgical stabilization of a flail chest wall]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bisphosphonates for the prevention of osteoporosis in patients treated with systematic corticosteroids: a review of the clinical evidence and guidelines
2011	NIHR Health Technology Assessment programme	Denosumab for osteoporotic fractures in post menopausal women primary and secondary prevention
2011	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness and safety of percutaneous treatment of pelvic ring fractures]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Percutaneous vertebroplasty and balloon kyphoplasty in treating painful osteoporotic vertebral compression fractures]
2011	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on the evaluation standards of osteoporosis in Korea]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Economic evaluation of joint replacement surgery alongside a multi-centre randomized trial in elderly patients with displaced femoral neck fractures]
2011	HAYES, Inc.	Taylor spatial frame (Smith&Nephew Inc.) for posttraumatic lower limb deformity
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Hip protectors in long-term care]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Risk factor analysis and probability of fragility fracture in a cohort of women with bone densitometry indication]
2010	Blue Cross Blue Shield Association (BCBS)	Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on osteoporosis and prevention of fragility fractures]
2010	National Institute for Health and Care Excellence (NICE)	Denosumab for the prevention of osteoporotic fractures in postmenopausal women. NICE technology appraisal guidance 204
2010	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Kyphoplasty and vertebroplasty for the treatment of osteoporotic vertebral compression fractures- observational study]
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Percutaneous vertebroplasty as a treatment for osteoporotic vertebral fractures - a health technology assessment]
2010	Medical Advisory Secretariat (MAS)	Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures
2010	Medical Advisory Secretariat (MAS)	Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update
2010	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost-utility analysis of pharmacological treatments for the prevention of bone fractures in osteoporotic post-menopausal Spanish women]
2010	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures - 1st Update 2010]
2010	Agency for Healthcare Research and Quality (AHRQ)	Screening for osteoporosis: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation
2010	HAYES, Inc.	Percutaneous vertebroplasty
2009	NIHR Health Technology Assessment programme	Vitamin K to prevent fractures in older women: a systematic review and economic evaluation
2009	HAYES, Inc.	Reclast (Novartis Pharmaceuticals Corp.) for bone loss prevention during breast cancer chemotherapy
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Morphogenetic bone for fracture healing: a review of the clinical-effectiveness and guidelines
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fluoridated water for cavity prevention: a review of the clinical-effectiveness, cost-effectiveness, and guidelines
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Percutaneous vertebroplasty in the treatment of osteoporotic vertebral fractures]
2009	Blue Cross Blue Shield Association (BCBS)	Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis
2009	Agency for Healthcare Research and Quality (AHRQ)	Treatment of common hip fractures
2009	HAYES, Inc.	Percutaneous sacroplasty for treatment of sacral insufficiency fractures
2009	HAYES, Inc.	Electrical bone growth stimulation, noninvasive
2008	NIHR Health Technology Assessment programme	A systematic review of the effectiveness of strategies for reducing the fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management
2008	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Clavicular fractures - a systematic review about efficacy and safety of different treatment options
2008	Blue Cross Blue Shield Association (BCBS)	Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis or malignancy
2008	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Systematic review
2008	HAYES, Inc.	Interferential therapy for pain and bone fractures
2008	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Clavicular fractures - a systematic review about efficacy and safety of different treatment options]
2008	NIHR Health Technology Assessment programme	A comparison of the effectiveness and cost-effectiveness of interventions for reducing the lifetime fracture risk in children with juvenile idiopathic arthritis - a systematic review with economic modelling
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hip protectors in long-term care: a clinical and cost-effectiveness review and primary economic evaluation
2008	Medical Advisory Secretariat (MAS)	The falls/fractures economic model in Ontario residents aged 65 years and over (FEMOR)
2007	Agency for Healthcare Research and Quality (AHRQ)	Effectiveness and safety of vitamin D in relation to bone health
2007	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
2007	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review
2007	The Swedish Council on Health Technology Assessment (SBU)	Percutaneous vertebroplasty in severe back pain from vertebral compression fractures - early assessment briefs (Alert)
2007	Institute for Clinical Effectiveness and Health Policy (IECS)	Kyphoplasty in the treatment of vertebral fractures caused by osteoporosis
2007	NIHR Health Technology Assessment programme	Strontium ranelate for the prevention of osteoporotic fractures in post-menopausal women with osteoporosis
2007	NIHR Health Technology Assessment programme	Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Wait times at the MUHC. No: 3 fracture management.
2007	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
2007	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diagnostic performance and costeffectiveness of technologies to measure bone mineral density in postmenopausal women
2007	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Parathyroid hormone (PTH) (Preotact®)
2006	Agency for Healthcare Research and Quality (AHRQ)	Multivitamin/mineral supplements and prevention of chronic disease
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Hyperbaric oxygen therapy: diagnostic usefulness and indications
2006	National Institute for Health and Care Excellence (NICE)	Balloon kyphoplasty for vertebral compression fractures. NICE interventional procedures guidance 166
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Teriparatide and bisphosphonates for treatment of osteoporosis in women: a clinical and economic analysis
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bisphosphonates and teriparatide for the prevention of osteoporotic fractures in postmenopausal women
2006	Blue Cross Blue Shield Association (BCBS)	Screening for vertebral fracture with dual x-ray absorptiometry
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bisphosphonates for the primary and secondary prevention of osteoporotic fractures in postmenopausal women: a meta-analysis
2006	ECRI	Percutaneous kyphoplasty for the treatment of vertebral fractures
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Aromatase inhibitors (anastrozole, letrozole and examestane) for adjuvant therapy in early breast cancer
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Bisphosphonates as treatment for breast cancer]
2005	Quality Improvement Scotland (NHS QIS )	Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
2005	NIHR Health Technology Assessment programme	Displaced intracapsular hip fractures in fit, older people: a randomised comparison of reduction and fixation, bipolar hemiarthroplasty and total hip arthroplasty
2005	The Swedish Council on Health Technology Assessment (SBU)	Aromatase inhibitors in breast cancer - early assessment briefs (Alert)
2005	ECRI	Recombinant human osteogenic protein-1 [rhOP-1] for healing nonunion fractures of the tibia
2005	ECRI	Percutaneous vertebroplasty for the treatment of vertebral fractures
2005	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
2005	NIHR Health Technology Assessment programme	Scottish trial of arthroplasty or reduction for subcapital fractures (STARS)- primary research
2005	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Teriparatide (parathyroid hormone) for treaing osteoporosis in women in post-menopause]
2005	Agency for Healthcare Research and Quality (AHRQ)	Percutaneous kyphoplasty for vertebral fractures caused by osteoporosis and malignancy and percutaneous vertebroplasty for vertebral fractures caused by osteoporosis and malignancy
2005	Institute for Clinical Effectiveness and Health Policy (IECS)	Extended adjuvant treatment with letrozole in breast cancer after 5 years of tamoxifen therapy
2005	Agency for Healthcare Research and Quality (AHRQ)	The role of bone growth stimulating devices and orthobiologics in healing nonunion fractures
2005	Blue Cross Blue Shield Association (BCBS)	Percutaneous vertebroplasty for vertebral fractures caused by osteoporosis or malignancy
2005	Blue Cross Blue Shield Association (BCBS)	Percutaneous kyphoplasty for vertebral fractures caused by osteoporosis or malignancy
2005	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of efficacy and safety evidence
2004	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	Percutaneous vertebroplasty. Pain management of osteoporotic vertebral fractures
2004	Institute for Clinical Systems Improvement (ICSI)	Vertebroplasty and balloon-assisted vertebroplasty for the treatment of osteoporotic compression fractures
2004	Blue Cross Blue Shield Association (BCBS)	Percutaneous kyphoplasty for vertebral fractures caused by osteoporosis and malignancy
2004	Blue Cross Blue Shield Association (BCBS)	Percutaneous vertebroplasty for vertebral fractures caused by osteoporosis and malignancy, or hemangioma
2004	Blue Cross Blue Shield Association (BCBS)	Vertebral assessment using dual-energy x-ray absorptiometry for osteoporotic fracture risk assessment
2004	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	Low-intensity ultrasound (Exogen (TM)) for the treatment of fractures
2004	Agency for Healthcare Research and Quality (AHRQ)	Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis
2004	HAYES, Inc.	Interferential therapy for pain and bone fractures
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Percutaneous vertebroplasty usefulness for vertebral fracture treatment
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of autologous growth factors in orthopaedic surgery
2004	Medical Advisory Secretariat (MAS)	Balloon kyphoplasty: an evidence-based analysis
2003	Norwegian Knowledge Centre for the Health Services (NOKC)	Prophylactic removal of wisdom teeth
2003	The Swedish Council on Health Technology Assessment (SBU)	Osteoporosis - prevention, diagnosis and treatment
2003	Alberta Heritage Foundation for Medical Research (AHFMR)	Hyperbaric oxygen therapy - recent findings on evidence for its effectiveness. Update
2003	Washington State Department of Labor and Industries (WSDLI)	Bone morphogenic protein for the treatment of long bone fractures and for use in spinal fusion procedures
2003	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	The value of ultrasound diagnostic technologies in the prevention of fractures in patients with osteoporosis (Early diagnosis of the risk for fractures)